FTC False Advertising Rules for Telehealth Ads

What counts as false or deceptive advertising?

The FTC's Truth in Advertising page says that when consumers see or hear an ad, "federal law says that ad must be truthful, not misleading, and, when appropriate, backed by scientific evidence." It applies "the same standards no matter where an ad appears", and it "looks especially closely at advertising claims that can affect consumers' health or their pocketbooks". A telehealth ad is both: it is about health, and it asks for payment (checked 3 Nov 2026).

The FTC's Health Products Compliance Guidance puts the starting rule in six words: "Advertising must be truthful and not misleading". It counts advertising "in social media and influencer marketing" as advertising, so paid social, creator and UGC ads are covered.

Health claims need scientific evidence

The guidance says "health-related products require substantiation in the form of competent and reliable scientific evidence". That is the standard for any claim about what a treatment, product or service does for a patient.

Softening the words does not lower the standard. The FTC says "it's not enough to say that the product "may" have the claimed benefit or "helps" achieve the claimed benefit." A claim with "may" or "helps" in it still needs the same evidence as the claim without them.

The net impression rule: implied claims count

The FTC judges an ad by what it leaves the viewer believing, not only by its literal words. Advertisers "should consider each ad as a whole, assessing the "net impression" conveyed by all elements of the ad", and "Marketers can't suggest benefits, safety, or other characteristics about their product indirectly that they couldn't claim directly."

The guidance gives a weight-loss example: people in lab coats in a laboratory setting. The FTC says these images give an impression of scientific legitimacy and likely carry an implied claim of clinical proof. For a telehealth ad, the setting, the props, the captions and the before-and-after framing are all part of the claim.

FDA status and disclaimers

Two points in the guidance matter for telehealth in particular:

• "Advertisers should be careful not to mischaracterize the extent to which a product or claim has been reviewed, authorized, or approved by the FDA."
• For supplements, the guidance says the DSHEA disclaimer or similar statements do not make an otherwise deceptive ad lawful.

Disclaimers also have to be seen. "If the claim requiring a disclosure is made both visually and audibly, the disclosure should be made both visually and audibly". And dramatic results cannot be fixed with a footnote: the guidance says disclaiming them with a line like "Results not typical" still leaves the ad deceptive.

Testimonials and creators

The FTC staff FAQ on the Endorsement Guides, which "were revised in 2023 with new or revised principles, examples, and definitions", covers reviews, testimonials and creators. An endorsement cannot carry a claim the brand could not make itself. An agency is responsible for employees who do not follow its instructions "(or who make unsubstantiated performance claims)", and "If law enforcement becomes necessary, our focus usually will be on advertisers or their ad agencies and public relations firms."

Who is liable for a deceptive ad?

The brand, and not only the brand. The Health Products guidance says "Anyone participating in deceptive marketing is potentially liable under FTC law", and lists the parties the FTC has acted against: "as well as ad agencies, distributors, retailers, catalog companies, infomercial producers, expert endorsers". An agency that writes or makes a deceptive telehealth ad is in that list.

The guidance is also clear about its own status: "The guide, however, doesn't have the force or effect of law." The law is the FTC Act; the guidance explains how the FTC applies it.

Earnings and business opportunity claims

A separate set of FTC rules covers ads that promise income, such as recruiting creators or affiliates with what they could earn. The FTC's Business Opportunity Rule guidance says the Rule applies to commercial arrangements where a seller solicits a buyer to enter a new business and the buyer "makes a required payment". Under it, "it's illegal to make an earnings claim unless you have written materials on hand that back up what you're saying", and earnings claims come with a separate document headed "EARNINGS CLAIM STATEMENT REQUIRED BY LAW".

The FTC has also sent a Notice of Penalty Offenses Concerning Money-Making Opportunities (2021), which lists "certain types of conduct that the FTC has determined, in one or more litigated administrative cases, to be unfair or deceptive". Whether a given program is a business opportunity under the Rule is a question for counsel.

How we apply this to telehealth ads

Telehealth Media makes paid social ads for telehealth brands, video and static, in batches of 10 ads, and every video is reviewed for compliance before delivery. We use only the claims a brand has cleared, and we check the whole ad, not just the script, against the net impression rule. See Meta ad policies for telehealth for the platform side.